studi
perform
rochest
gener
hospit
rochest
new
york
adult
age
year
admit
emerg
depart
diagnos
compat
acut
respiratori
tract
infect
recruit
novemb
may
winter
patient
screen
within
hour
hospit
exclud
given
antibiot
prior
admiss
immunosuppress
cavitari
lung
diseas
wit
aspir
inform
consent
obtain
subject
legal
guardian
studi
approv
univers
rochest
rochest
gener
hospit
institut
review
board
enrol
demograph
clinic
laboratori
inform
collect
provid
uniform
primari
clinic
admit
diagnosi
assign
pulmonari
specialist
examin
subject
review
laboratori
radiograph
find
subject
underw
test
bacteri
pathogen
includ
blood
cultur
sputum
cultur
gram
stain
streptococcu
pneumonia
urin
antigen
pneumococc
serolog
test
pcr
sputum
nose
throat
swab
specimen
mycoplasma
pneumonia
chlamydophila
pneumonia
sputum
induc
normal
salin
subject
unabl
expector
sampl
consid
adequ
basi
standard
criteria
nose
throat
swab
sputum
specimen
test
virus
revers
transcript
pcr
rtpcr
sera
collect
admiss
week
later
viral
pneumococc
serolog
test
serum
also
collect
hospit
day
pct
measur
blood
cultur
sputum
gram
stain
cultur
influenza
viru
antigen
test
viral
cultur
perform
rochest
gener
hospit
clinic
laboratori
result
avail
clinician
patient
care
sputum
sampl
plate
blood
chocol
macconkey
agar
legionella
test
sputum
cultur
urinari
antigen
assay
perform
discret
treat
physician
singl
blood
cultur
posit
organ
consist
skin
flora
ie
coagulaseneg
staphylococcu
corynebacterium
hemolyt
streptococci
propionibacterium
acn
consid
contamin
sputum
cultur
consid
posit
rare
pathogen
bacteria
grew
adequ
sampl
except
legoinella
pneumococc
surfac
protein
antigen
cover
famili
obtain
univers
alabama
bacteri
respiratori
pathogen
refer
laboratori
use
enzym
immunoassay
rise
titer
consid
evid
infect
urin
sampl
assay
pneumococc
antigen
use
binax
urin
assay
binax
scarborough
pct
level
measur
resolv
amplifi
cryptat
emiss
technolog
kryptor
pct
brahm
henningsdorf
germani
function
sensit
assay
ngml
mean
normal
level
ngml
immunoglobulin
g
titer
acut
convalescentphas
serum
specimen
determin
use
establish
method
influenza
b
virus
respiratori
syncyti
viru
human
metapneumoviru
parainfluenza
type
human
coronavirus
rise
viral
specif
immunoglobulin
g
level
consid
evid
infect
assay
respiratori
syncyti
viru
human
metapneumoviru
mycoplasma
pneumonia
chlamydophila
pneumonia
perform
use
publish
method
human
rhinoviru
assay
perform
basi
method
publish
lu
et
al
follow
modif
forward
primer
primer
probe
virus
follow
influenza
viru
matrix
gene
influenza
b
viru
gene
human
coronavirus
polymeras
gene
parainfluenza
virus
nucleocapsid
gene
sequenc
suppli
request
viru
infect
alon
defin
nose
throat
swab
sampl
sputum
sampl
posit
viru
one
follow
assay
rtpcr
virus
rapid
influenza
antigen
test
serolog
analysi
virus
except
detect
ill
coincid
influenza
vaccin
addit
criteria
involv
neg
result
test
bacteria
serum
pct
valu
ngml
admiss
day
bacteri
infect
alon
defin
basi
neg
result
viral
diagnost
test
follow
posit
blood
cultur
result
cultur
adequ
sputum
sampl
posit
respiratori
pathogen
urinari
antigen
test
posit
pneumonia
legionella
pneumophila
serolog
assay
posit
pneumococci
pcr
assay
posit
pneumonia
c
pneumonia
serum
pct
level
ng
admiss
hospit
day
mix
viralbacteri
infect
met
definit
bacteri
infect
viral
infect
continu
variabl
compar
use
nonparametr
wilcoxon
test
categor
variabl
compar
use
fisher
exact
test
pearson
correl
coeffici
use
summar
depend
pair
continu
variabl
univari
analysi
compar
mix
viralbacteri
infect
viral
infect
alon
falsediscoveri
rate
use
account
multipl
comparison
multipl
logist
regress
analysi
use
model
outcom
mix
viralbacteri
infect
vs
viral
infect
alon
function
subset
candid
predictor
includ
age
year
katz
function
score
symptom
day
temperatur
puls
rate
systol
blood
pressur
beatsmin
score
oxygen
satur
level
peripher
white
blood
cell
count
wbc
cellsml
anion
gap
blood
urea
nitrogen
level
sex
diabet
mellitu
congest
heart
failur
copd
chronic
renal
failur
activ
smoke
steroid
use
influenza
vaccin
clinic
admiss
diagnos
pneumonia
acut
exacerb
copd
bronchiti
congest
heart
failur
asthma
viral
infectioninfluenza
diagnosi
nasal
congest
sputum
product
confus
wheez
rale
posit
viral
pcr
find
radiograph
find
ie
acut
diseas
infiltr
variabl
includ
miss
valu
includ
pneumococc
vaccin
statu
percentag
neutrophil
band
form
peripher
blood
basal
metabol
index
studi
period
hospit
appropri
admiss
diagnos
screen
hospit
exclud
follow
reason
prior
antibiot
use
immunosuppress
wit
aspir
follow
possibl
hospit
exclud
reason
hospit
elig
inclus
involv
patient
abl
give
consent
involv
patient
refus
particip
thu
hospit
involv
patient
consent
particip
includ
studi
figur
microbiolog
diagnosi
made
hospit
involv
bacteri
infect
alon
evid
viral
infect
involv
viral
infect
viral
infect
alon
evid
mix
viralbacteri
infect
basi
specif
bacteri
test
identifi
basi
elev
serum
pct
level
report
focu
hospit
document
viral
infect
tabl
viral
diagnosi
made
basi
rtpcr
find
hospit
basi
serolog
test
alon
remain
tabl
influenza
viru
common
viru
account
hospit
follow
respiratori
syncyti
viru
human
coronaviru
influenza
b
viru
least
frequent
viru
detect
thirtyeight
hospit
associ
multipl
virus
primari
clinic
diagnos
associ
viru
infect
acut
exacerb
copd
hospit
pneumonia
acut
bronchiti
asthma
exacerb
clinic
admiss
diagnos
similar
pathogen
although
rate
pneumonia
lowest
human
rhinoviru
hospit
highest
human
metapneumoviru
human
coronaviru
signific
differ
rate
mix
viralbacteri
infect
viral
pathogen
includ
pandem
bacteri
coinfect
rate
hospit
involv
mix
viralbacteri
infect
specif
bacteri
pathogen
document
diagnosi
confirm
blood
cultur
hospit
sputum
cultur
pneumococc
urinari
antigen
test
pneumococc
serolog
test
atyp
bacteria
rare
identifi
pneumonia
hospit
c
pneumonia
first
year
therefor
test
discontinu
third
year
pneumonia
account
bacteri
diagnos
figur
hospit
involv
viral
infect
either
admiss
day
pct
measur
valu
avail
correl
day
pct
level
high
r
p
overal
hospit
least
pct
measur
involv
patient
level
ngml
tabl
basi
posit
bacteri
test
result
pct
level
ngml
admiss
day
hospit
involv
viral
ill
evid
mix
viralbacteri
infect
tabl
involv
posit
result
bacteri
test
elev
pct
level
involv
posit
result
bacteri
test
involv
elev
pct
level
note
despit
vigor
attempt
collect
adequ
sputum
time
fashion
frequent
unabl
procur
adequ
sputum
within
hour
antibiot
administr
thu
hospit
bacteri
infect
defin
basi
pct
level
alon
neg
result
sputum
cultur
consid
unreli
compar
group
whole
hospit
associ
elev
pct
level
without
posit
result
bacteri
test
involv
patient
similar
respect
age
rate
pneumonia
physic
examin
find
sever
ill
score
contrast
hospit
associ
low
pct
valu
posit
bacteri
test
result
involv
patient
younger
lower
sever
ill
score
less
like
receiv
diagnosi
pneumonia
vs
p
like
receiv
diagnosi
asthma
copd
exacerb
vs
p
compar
associ
elev
pct
valu
clinic
laboratori
variabl
compar
accord
bacteri
test
posit
tabl
surprisingli
hospit
associ
posit
blood
cultur
result
involv
patient
higher
sever
ill
score
abnorm
find
laboratori
test
compar
associ
posit
result
bacteri
test
associ
posit
bacteri
test
result
consist
differ
group
note
respect
admiss
diagnos
radiolog
find
bacterem
hospit
involv
significantli
greater
percentag
pct
measur
ngml
compar
involv
posit
result
bacteri
test
vs
p
note
singl
hospit
involv
bacterem
subject
low
pct
level
yield
clinic
diagnosi
bronchiti
blood
cultur
posit
multipl
organ
enterococci
staphylococcu
aureu
coagulaseneg
staphylococci
rais
possibl
blood
cultur
contamin
addit
median
pct
valu
higher
group
posit
bacteri
test
result
compar
posit
bacteri
test
result
bacteremia
p
urin
antigen
test
p
pneumococc
serolog
test
p
sputum
cultur
alon
p
compar
subject
ill
characterist
among
hospit
involv
viral
infect
alon
involv
mix
viralbacteri
infect
use
combin
posit
microbiolog
test
andor
serum
pct
level
ng
defin
bacteri
infect
number
clinic
featur
significantli
differ
univari
analysi
shown
tabl
among
hospit
associ
mix
viralbacteri
infect
subject
older
higher
rate
chronic
renal
failur
commonli
receiv
diagnos
pneumonia
less
commonli
receiv
diagnos
acut
exacerb
copd
asthma
subject
also
significantli
lower
systol
blood
pressur
well
significantli
higher
mean
puls
rate
peripher
white
blood
cell
count
band
form
anion
gap
blood
urea
nitrogen
level
although
substanti
overlap
valu
multivari
analysi
shown
tabl
indic
factor
mostli
strongli
predict
mix
viralbacteri
infect
p
peripher
white
blood
cell
count
cellsml
odd
ratio
anion
gap
per
unit
chang
copd
chronic
renal
failur
infiltr
chest
radiograph
although
sever
ill
score
significantli
higher
among
hospit
involv
mix
viralbacteri
infect
rate
intens
care
use
length
stay
inhospit
mortal
significantli
differ
group
tabl
followup
patient
hospit
mix
viralbacteri
infect
continu
requir
higher
level
medic
care
frequent
hospit
without
bacteri
infect
month
outcom
group
similar
hospit
deem
involv
viral
infect
alon
patient
treat
antibiot
patient
judg
involv
mix
viralbacteri
infect
tabl
although
patient
hospit
bacteri
infect
treat
longer
hospit
viral
infect
alon
mean
treatment
durat
vs
falsediscoveri
rate
potenti
antibioticrel
advers
event
significantli
common
mix
viralbacteri
group
compar
viral
infect
alon
falsediscoveri
rate
notabl
death
among
patient
hospit
viral
infect
alon
secondari
complic
clostridium
difficil
coliti
studi
largest
publish
prospect
assess
bacteri
coinfect
patient
viral
respiratori
diseas
requir
hospit
use
comprehens
bacteri
test
plu
serum
biomark
pct
defin
bacteri
infect
data
indic
nearli
viralassoci
hospit
evid
concomit
bacteri
infect
recent
studi
pandem
influenza
show
overal
rate
bacteri
coinfect
among
critic
ill
children
adult
among
fatal
ill
much
less
known
regard
bacteri
complic
viral
respiratori
tract
infect
particularli
adult
data
indic
rate
type
bacteri
infect
virus
similar
observ
influenza
high
rate
mix
viralbacteri
infect
identifi
studi
reflect
use
serum
biomark
pct
augment
comprehens
bacteri
test
previou
studi
report
bacteri
complic
viral
infect
bacteri
test
neither
comprehens
systemat
frequent
left
discret
clinician
care
patient
although
number
clinic
laboratori
variabl
associ
mix
bacterialvir
infect
absolut
differ
individu
variabl
hospit
involv
viral
infect
alon
small
unlik
help
patient
manag
nevertheless
studi
subject
hospit
mix
bacterialvir
infect
ill
hospit
viral
infect
alon
administr
earli
appropri
antibiot
patient
import
howev
also
noteworthi
hospit
involv
viral
infect
evid
bacteri
infect
individu
normal
chest
radiograph
find
hemodynam
stabl
yet
receiv
cours
antibiot
treatment
four
death
due
complic
c
difficil
coliti
occur
group
consid
nuisanc
c
difficil
coliti
evolv
deadli
syndrom
high
mortal
rate
relaps
rate
data
highlight
critic
need
better
method
safe
reduc
unnecessari
use
antibiot
recent
european
studi
suggest
pctguid
algorithm
reason
altern
tradit
microbiologyguid
antibiot
therapi
trial
involv
subject
cap
acut
exacerb
copd
randomli
assign
receiv
standard
care
pctguid
antibiot
treatment
discern
advers
outcom
antibiot
use
significantli
decreas
especi
nonpneumon
respiratori
tract
infect
studi
serum
pct
level
ngml
correl
radiograph
pneumonia
higher
sever
ill
score
previous
note
consist
pct
level
surrog
invas
bacteri
infect
addit
higher
mean
pct
level
note
patient
receiv
diagnosi
bacteri
infect
varieti
method
includ
blood
sputum
cultur
well
pneumococc
urin
antigen
serolog
test
suggest
elev
pct
level
heighten
clinician
suspicion
bacteri
infect
howev
pct
level
may
correl
well
less
invas
bacteri
infect
bronchiti
acut
exacerb
copd
thu
patient
low
pct
level
may
rule
presenc
bacteri
infect
although
issu
bacteri
colon
popul
complic
interpret
examin
sputum
may
continu
import
patient
sever
underli
lung
diseas
studi
number
limit
first
result
applic
adult
rate
mix
bacterialvir
infect
may
quit
differ
children
addit
result
may
applic
adult
admit
respiratori
tract
infect
sinc
ill
studi
sever
reflect
low
mortal
rate
inabl
obtain
consent
critic
ill
patient
may
underestim
rate
mix
viralbacteri
infect
also
despit
vigor
attempt
collect
adequ
respiratori
sampl
time
fashion
success
hospit
also
lead
underestim
bacteri
infect
convers
also
possibl
bacteri
infect
base
result
sputum
cultur
overestim
incid
infect
often
possibl
distinguish
chronic
colon
infect
even
adequ
sampl
last
presenc
viral
rna
may
alway
causal
associ
ill
lead
hospit
prolong
viral
detect
follow
respiratori
tract
infect
due
rhinoviru
virus
seen
particularli
use
sensit
molecular
diagnost
test
conclus
bacteri
coinfect
associ
approxim
seriou
respiratori
viral
infect
adult
requir
hospit
patient
posit
result
viral
test
care
evalu
concomit
bacteri
infect
prudent
initi
earli
empir
antibiot
therapi
patient
sever
viral
ill
definit
radiograph
pneumonia
present
time
establish
specif
bacteri
diagnosi
basi
tradit
method
remain
difficult
better
bacteri
diagnost
test
need
futur
studi
need
develop
treatment
algorithm
use
combin
biomark
clinic
paramet
accur
predict
patient
low
risk
bacteri
infect
antibiot
may
safe
discontinu
